Customized services to meet your needs.
35+ languages
Our team of specialists is proficiently trained in AE and PQC reporting while also providing exceptional levels of service.
Experience with Community Management Services across the globe. Complying with various regulatory bodies.
Facebook, Instagram, LinkedIn, X, and more.
ProPharma diligently oversees our clients' social media channels, monitoring for any emerging Adverse Events or Product Complaints. Whenever we spot something reportable, we promptly document and report our findings within the required timeframe, ensuring that critical information is not missed.
ProPharma actively engages with consumer comments and inquiries across various social media platforms acting as the client. We utilize a client-approved standard response document tailored specifically for these interactions. Whether responding publicly to comments beneath posts or privately through direct messages, ProPharma ensures that each interaction is professional, appropriate, and non-promotional. With this service, ProPharma will also remove inappropriate comments from your posts to keep your company’s image professional.
We are dedicated to enhancing the health and well-being of consumers through our comprehensive Community Management services. Whether you need reliable Social Media Monitoring Services or full service including Social Response Management, our team of experts is here to help.
May 5, 2026
Preparing for an IND submission? Discover 12 critical questions sponsors should answer to reduce FDA risk, avoid delays, and strengthen submission readiness.
April 30, 2026
Recent cyberattacks on MedTech leaders highlight growing regulatory and patient safety risks. Explore key lessons and how FDA cybersecurity guidance is shaping compliance and resilience.
April 27, 2026
Explore how Consumer Health brands can enhance consumer engagement through proactive service strategies, ensuring safety, compliance, and brand loyalty in a complex market.
January 27, 2026
ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.
December 11, 2025
ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.
July 8, 2025
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
%20-%2004May2026.png?width=320&height=185&name=IND%20Readiness%20Diagnostic%20(RS)%20-%2004May2026.png)
%20-%20September%202025.png?width=320&height=185&name=Expedited%20Promotional%20Materials%20Review%20Case%20Study%20(RS)%20-%20September%202025.png)
.png?width=320&height=185&name=4%20-%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
.png?width=320&height=185&name=Webinar%20Thumbnail%20Quality%20%26%20Compliance%20(650%20x%20425%20px).png)
